Development and optimization of levodopa and benzylhydrazine orally disintegrating tablets by direct compression and response surface methodology
The number of Parkinson's disease (PD) patients with the advanced phase and motor fluctuations is increasing. The objective of this study is developing levodopa/benzylhydrazine orally disintegrating tablets (L/B ODTs), which would provide greater convenience and ease of use than conventional ta...
Gespeichert in:
Veröffentlicht in: | Drug development and industrial pharmacy 2020-01, Vol.46 (1), p.42-49 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!